SCI FRAC is a global business development, sales, and marketing agency focused on driving topline growth for Biotech, Pharma, and CDMO/CRO companies. We offer fractional executive leadership and tailored strategies to accelerate market expansion, boost sales, and enhance commercialization. Our expertise helps life sciences companies rapidly scale, close business development gaps, and achieve sustainable growth in the competitive biotech and pharma sectors.

Responsible for the End-to-End CDMO Business Development activities including Cell Gene Therapies: GMP Plasmid, AAV, LVV, RVV, mRNA, Biologics, Cell line Development, DP SFF solution offerings.• Lead and direct all Business Development and Commercial Operations activities for North America• Oversee and manage a team of twelve remote direct reports.• Drive revenue growth by developing and executing annual and medium-term growth plans, focusing on achieving set sales targets from both existing and new customers.• Own P&L top-line and financial targets; serve as a member of the Executive Leadership Team• Identify and pursue client RFP opportunities that align with the company’s service offerings and strategic direction.• Collaborate closely with the strategic marketing intelligence team to develop competitive market analysis and support the creation of the company’s strategic commercial plan, including sales targets and opportunities.• Cultivate and maintain relationships with key stakeholders, including leading Biopharmaceutical companies and industry partners.• Negotiate and execute complex master service agreements that align with the company’s strategic interests.•Drive revenue generation by identifying new business opportunities and collaborating with cross-functional teams to ensure the successful delivery of services that meet client expectations.• Development and implement business process for streamline improvements• Build, mentor, and lead a high-performing business development team• Foster a positive work environment that supports career growth and professional development. • Attend key biopharma trade conferences to generate new leads, network with potential clients, and identify business opportunities

Responsible for Global End to End CDMO Business Development activities including:• Identifying new client business opportunities within the global Biopharma industry • Areas of focus include Drug Product Sterile Fill & Finish manufacturing services • Initiate sales activity for small molecule, biologics, and vaccine DP filling solutions• Manage global key accounts and the relationships with C-suite key decision makers• Personalize and develop the client's CMC roadmap for program success• CMC Technical Upstream and Downstream manufacturing process knowledge DS & DP• Lead client RFP technical and facility fit evaluations, MSA negotiation and execution• Develop Strategic partnerships and deal sourcing • Direct daily collaboration with multiple Recipharm global manufacturing sites • Provide professional guidance, coaching and mentoring to junior level staff• Manage Alliance & Program management for existing clients• Plan and execute strategic portfolio assessments and enhancements for clients• Conduct market landscape and competitor analysis • M&A, Joint Venture evaluation and execution• Attend Biopharma trade conferences for new client and network opportunities• P/L and Financial target responsibility• Long term strategic outlook for Recipharm and the SFF BU

Responsible for Global End to End Biologics CDMO Business Development activities including:• Identify new client business opportunities within the global Biopharma industry • Initiate sales activity for Small & Large scale drug substance, drug product and CRO services• Strategic partnership deal sourcing, RFP, facility fit eval's, contract negotiation and execution• Personalize and develop client CMC roadmap for their contracted program requirements• Responsibility of managing 130+ key global accounts and networking with key decision makers• Solution provider for biologic cell line development and clinical supply services • Alliance & Program management for existing clients• Plan and execute strategic ongoing product portfolio assessments and enhancements for clients• M&A and Joint Venture evaluation and execution• Attend Biopharma trade conferences and events for new client and network opportunities• Long term strategic outlook

Strategic Partnership Lead, within Amgen’s Global Operations department with the direct alliance and CMC supply management of multiple out licensed programs that focus on strategically selected markets for clinical and commercialization programs through selected alliances. Area of contractual expertise: Out-license, collaborations, development, co-promotion, commercial and clinical supply. Current therapeutic area programs include Oncology, Nephrology and Anti-Inflammatory.• Lead new market introduction for pre-post launch readiness alignment for multiple commercialized out-licensed programs within Japan (in alliance with Ono Pharmaceutical Osaka, Japan). Key programs include (AMG 981- Kyprolis (Carfilzomib), AMG 982 - Oprozomib, AMG 416 – Parsabiv, AMG 827 - Bausch Health• Lead and manage both clinical FIH and Non-FIH phase one, Phase two out- licensed programs that are operationally complex and require cross functional knowledge and collaboration to execute contractual obligations of existing and future drug substance/drug product supply in conjunction with CMC technical• Knowledge know-how transfers providing the ability for selected alliances to manufacture drug substance and drug product supply. Key programs include (in alliance with Stanford University AMG 191, Genentech AMG 282, Kartos AMG 232, Acerta AMG 319, Akero AMG 876, NantCell AMG 479, NantPharma AMG 337, Pfizer - Enbrel).• Charter and lead all Joint Operation and Business Planning governance meetings to ensure program progression, identify critical issues and execute required action items for resolution to guarantee program accountability and success. (Core / non-core JOT members include (GOL, PQL, QA, AS, DS, DP, PD, GSC, BD, CD, ACM, legal)• Operate daily within a cGMP-regulated environment, including knowledge of relevant US/EU regulatory and quality requirements, standards, practices, and statues.• Pre-deal CMC agreement review and guidance for out license input.

Directed and managed a robust supply chain and the product management of high demand commercial agriculture seed varieties more than $125M globally that are in short supply. Ensure fair product allocation to maximum profitability by utilizing financial, analytical and market strategy background.• Managed the allocation of >100 commercial products utilizing market landscape and financial strategy methods• Re-channeled >$10M+ in surplus inventories over the last four years to prevent financial write-offs.• Directed the approval of both short and long-term marketing strategies on high impact products and markets• Enhanced P/L profitability by working directly with regional marketing and commercial teams for supply review and market plan for fast spot invoicing

General Manager - Expatriate assignment responsible for managing a >$30M P/L for a hybrid agriculture business unit for the West Asia business region. (Commercial, Marketing, SG&A, Finance, OPS, HR)• Developed and achieved yearly business unit sales goals while on assignment >$30M with >10% to 15% CAGR per year• Enhanced regional business unit profitability by merger and acquisition of an additional local agriculture company for $1.8M USD which resulted in contributing to an additional market share increase. • Raised efficiencies by re-organizing and implementing new credit control policies that assisted in the collecting of over >$3M USD in outstanding account receivables from West Asia based clients > 120 days outstanding.• Reduced SG&A costs by implementing new improved internal policies that reduced yearly spend by $300K USD.• Increase Customer Satisfaction by effectively traveling throughout West Asia to meet with commercial customers to re-establish business relationships and rebuild trust and confidence with Monsanto brand and staff.• Direct Management and mentorship of 40+ direct reports and 100 non-direct reports under my responsibility as GM with positive results.• Served on the Board of Directors

June 1986 – July 1991 Active Duty (5 years 2 months)July 1991 – July 2012 – Reserve (21 years)0369 - Operations Chief - MARFORPAC G3